Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
Source abstract
Abstract
Gold nanoparticles have attracted enormous scientific and technological interest due to their ease of synthesis, chemical stability, and unique optical properties. Proof-of-concept studies demonstrate their biomedical applications in chemical sensing, biological imaging, drug delivery, and cancer treatment. Knowledge about their potential toxicity and health impact is essential before these nanomaterials can be used in real clinical settings. Furthermore, the underlying interactions of these nanomaterials with physiological fluids is a key feature of understanding their biological impact, and these interactions can perhaps be exploited to mitigate unwanted toxic effects. In this Perspective we discuss recent results that address the toxicity of gold nanoparticles both in vitro and in vivo, and we provide some experimental recommendations for future research at the interface of nanotechnology and biological systems.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Aillon KL, Xie YM, El-Gendy N, Berkland CJ, Forrest ML (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–466. doi:10.1016/j.addr.2009.03.01010.1016/j.addr.2009.03.010 ↗
2. Alivisatos AP (1996) Semiconductor clusters, nanocrystals, and quantum dots. Science 271:933–93710.1126/science.271.5251.933 ↗
3. Alkilany AM, Murphy CJ (2009) Gold nanoparticles with a polymerizable surfactant bilayer: synthesis, polymerization, and stability evaluation. Langmuir 25:13874–13879. doi:10.1021/la901270x10.1021/la901270x ↗
4. Alkilany AM, Frey RL, Ferry JL, Murphy CJ (2008) Gold nanorods as nanoadmicelles: 1-naphthol partitioning into a nanorod-bound surfactant bilayer. Langmuir 24:10235–10239. doi:10.1021/la801834310.1021/la8018343 ↗
5. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD (2009) Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 5:701–708. doi:10.1002/smll.20080154610.1002/smll.200801546 ↗
6. Anker JN, Hall WP, Lyandres O, Shah NC, Zhao J, Van Duyne RP (2008) Biosensing with plasmonic nanosensors. Nat Mater 7:442–453. doi:10.1038/nmat216210.1038/nmat2162 ↗
7. AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290. doi:10.1021/nn800596wER10.1021/nn800596w ↗
8. Au L, Zhang Q, Cobley CM et al (2010) Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 4:35–42. doi:10.1021/nn901392mER10.1021/nn901392m ↗
9. Ballou B, Ernst LA, Andreko S et al (2007) Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 18:389–396. doi:10.1021/bc060261j10.1021/bc060261j ↗
10. Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY (2009) Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5:1897–1910. doi:10.1002/smll.20080171610.1002/smll.200801716 ↗
11. Bastus NG, Sanchez-Tillo E, Pujals S et al (2009) Peptides conjugated to gold nanoparticles induce macrophage activation. Mol Immunol 46:743–748. doi:10.1016/j.molimm.2008.08.27710.1016/j.molimm.2008.08.277 ↗
12. Cedervall T, Lynch I, Foy M et al (2007) Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 46:5754–5756. doi:10.1002/anie.20070046510.1002/anie.200700465 ↗
13. Chen YS, Hung YC, Liau I, Huang GS (2009) Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 4:858–864. doi:10.1007/s11671-009-9334-610.1007/s11671-009-9334-6 ↗
14. Chithrani BD, Chan WCW (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542–1550. doi:10.1021/nl070363y10.1021/nl070363y ↗
15. Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668. doi:10.1021/nl052396o10.1021/nl052396o ↗
16. Cho EC, Xie JW, Wurm PA, Xia YN (2009a) Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett 9:1080–1084. doi:10.1021/nl803487r10.1021/nl803487r ↗
17. Cho WS, Cho MJ, Jeong J et al (2009b) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24. doi:10.1016/j.taap.2008.12.02310.1016/j.taap.2008.12.023 ↗
18. Cho EC, Liu Y, Xia Y (2010) A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures. Angew Chem Int Ed 49:1976–1980. doi:10.1002/anie.20090658410.1002/anie.200906584 ↗
19. Choi HS, Liu W, Misra P et al (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165–1170. doi:10.1038/nbtl34010.1038/nbt1340 ↗
20. Colvin VL (2003) The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166–1170. doi:10.1038/nbt87510.1038/nbt875 ↗
21. Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–44. doi:10.1038/nature01451ER10.1038/nature01451 ↗
22. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327. doi:10.1002/smll.20040009310.1002/smll.200400093 ↗
23. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–1919. doi:10.1016/j.biomaterials.2007.12.03710.1016/j.biomaterials.2007.12.037 ↗
24. Dickerson EB, Dreaden EC, Huang XH et al (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269:57–66. doi:10.1016/j.canlet.2008.04.02610.1016/j.canlet.2008.04.026 ↗
25. Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469–478. doi:10.1038/nnano.2007.22310.1038/nnano.2007.223 ↗
26. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495. doi:10.1021/mp800032f10.1021/mp800032f ↗
27. Dobrovolskaia MA, Patri AK, Zheng JW et al (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–117. doi:10.1016/j.nano.2008.08.00110.1016/j.nano.2008.08.001 ↗
28. Eghtedari M, Oraevsky A, Copland JA, Kotov NA, Conjusteau A, Motamedi M (2007) High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system. Nano Lett 7:1914–1918. doi:10.1021/nl070557d10.1021/nl070557d ↗
29. Eghtedari M, Liopo AV, Copland JA, Oraevslty AA, Motamedi M (2009) Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett 9:287–291. doi:10.1021/nl802915q10.1021/nl802915q ↗
30. Fako VE, Furgeson DY (2009) Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev 61:478–486. doi:10.1016/j.addr.2009.03.00810.1016/j.addr.2009.03.008 ↗
31. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171. doi:10.1038/nrc156610.1038/nrc1566 ↗
32. Ferry JL, Craig P, Hexel C et al (2009) Transfer of gold nanoparticles from the water column to the estuarine food web. Nat Nanotechnol 4:441–444. doi:10.1038/NNANO.2009.157ER10.1038/nnano.2009.157 ↗
33. Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A (1976) Auranofin: new oral gold compound for treatment of rheumatoid-arthritis. Ann Rheum Dis 35:251–257. doi:10.1136/ard.35.3.25110.1136/ard.35.3.251 ↗
34. Fischer HC, Chan WCW (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–571. doi:10.1016/j.copbio.2007.11.00810.1016/j.copbio.2007.11.008 ↗
35. Gao HJ, Shi WD, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102:9469–9474. doi:10.1073/pnas.050387910210.1073/pnas.0503879102 ↗
36. Goodman CM, McCusker CD, Yilmaz T, Rotello VM (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897–900. doi:10.1021/bc049951i10.1021/bc049951i ↗
37. Griffith LG, Swartz MA (2006) Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7:211–224. doi:10.1038/nrm185810.1038/nrm1858 ↗
38. Grzelczak M, Perez-Juste J, Mulvaney P, Liz-Marzan LM (2008) Shape control in gold nanoparticle synthesis. Chem Soc Rev 37:1783–1791. doi:10.1039/b711490g10.1039/b711490g ↗
39. Gu YJ, Cheng JP, Lin CC, Lam YW, Cheng SH, Wong WT (2009) Nuclear penetration of surface functionalized gold nanoparticles. Toxicol Appl Pharmacol 237:196–204. doi:10.1016/j.taap.2009.03.00910.1016/j.taap.2009.03.009 ↗
40. Han G, Ghosh P, Rotello VM (2007) Functionalized gold nanoparticles for drug delivery. Nanomedicine 2:113–123. doi:10.2217/17435889.2.1.11310.2217/17435889.2.1.113 ↗
41. Hauck TS, Ghazani AA, Chan WCW (2008) Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4:153–159. doi:10.1002/smll.20070021710.1002/smll.200700217 ↗
42. Helmus M (2007) The need for rules and regulations. Nat Nanotechnol 2:333–334. doi:10.1038/nnano.2007.16510.1038/nnano.2007.165 ↗
43. Hess H, Tseng Y (2007) Active intracellular transport of nanopartides: opportunity or threat? ACS Nano 1:390–392. doi:10.1021/nn700407v10.1021/nn700407v ↗
44. Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90:1927–1936. doi:10.1002/jps.114310.1002/jps.1143 ↗
45. Hirsch LR, Stafford RJ, Bankson JA et al (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100:13549–13554. doi:10.1073/pnas.223247910010.1073/pnas.2232479100 ↗
46. Jain PK, Huang XH, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41:1578–1586. doi:10.1021/ar700280410.1021/ar7002804 ↗
47. Jia HY, Liu Y, Zhang XJ et al (2009) Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum. J Am Chem Soc 131:40–41. doi:10.1021/ja808033w10.1021/ja808033w ↗
48. Kattumuri V, Katti K, Bhaskaran S et al (2007) Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 3:333–341. doi:10.1002/smll.20060042710.1002/smll.200600427 ↗
49. Kelly KL, Coronado E, Zhao LL, Schatz GC (2003) The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem B 107:668–677. doi:10.1021/jp026731y10.1021/jp026731y ↗
50. Khan JA, Pillai B, Das TK, Singh Y, Maiti S (2007) Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem 8:1237–1240. doi:10.1002/cbic.20070016510.1002/cbic.200700165 ↗
51. Lal S, Clare SE, Halas NJ (2008) Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 41:1842–1851. doi:10.1021/ar800150g10.1021/ar800150g ↗
52. Lee J, Lilly GD, Doty RC, Podsiadlo P, Kotov NA (2009) In vitro toxicity testing of nanoparticles in 3D cell culture. Small 5:1213–1221. doi:10.1002/smll.20080178810.1002/smll.200801788 ↗
53. Leonov AP, Zheng JW, Clogston JD, Stern ST, Patri AK, Wei A (2008) Detoxification of gold nanorods by treatment with polystyrenesulfonate. ACS Nano 2:2481–2488. doi:10.1021/nn800466c10.1021/nn800466c ↗
54. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4:26–49. doi:10.1002/smll.20070059510.1002/smll.200700595 ↗
55. Liu YL, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL (2007) Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal Chem 79:2221–2229. doi:10.1021/ac061578f10.1021/ac061578f ↗
56. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40–47. doi:10.1016/S1748-0132(08)70014-810.1016/S1748-0132(08)70014-8 ↗
57. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA (2007) The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134–135:167–174. doi:10.1016/j.cis.2007.04.02110.1016/j.cis.2007.04.021 ↗
58. Marquis BJ, Love SA, Braun KL, Haynes CL (2009) Analytical methods to assess nanoparticle toxicity. Analyst 134:425–439. doi:10.1039/b818082b10.1039/b818082b ↗
59. Maynard AD, Aitken RJ, Butz T et al (2006) Safe handling of nanotechnology. Nature 444:267–269. doi:10.1038/444267a10.1038/444267a ↗
60. Metz O, Stoll W, Plenert W (1982) Meningosis prophylaxis with intrathecal Au-198-colloid and methotrexate in childhood acute lymphocytic-leukemia. Cancer 49:224–228. doi:10.1002/1097-0142(1982115)49:2<224:AID-CNCR2820490205>3.0.CO;2-O10.1002/1097-0142(19820115)49:2<224::AID-CNCR2820490205>3.0.CO;2-O ↗
61. Murphy CJ, San TK, Gole AM et al (2005a) Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chem B 109:13857–13870. doi:10.1021/jp051684610.1021/jp0516846 ↗
62. Murphy CJ, Sau TK, Gole A, Orendorff CJ (2005b) Surfactant-directed synthesis and optical properties of one-dimensional plasmonic metallic nanostructures. MRS Bull 30:349–35510.1557/mrs2005.97 ↗
63. Murphy CJ, Gole AM, Hunyadi SE et al (2008a) Chemical sensing and imaging with metallic nanorods. Chem Commun 5:544–557. doi:10.1039/b711069c10.1039/b711069c ↗
64. Murphy CJ, Gole AM, Stone JW et al (2008b) Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 41:1721–1730. doi:10.1021/ar800035u10.1021/ar800035u ↗
65. Nativo P, Prior IA, Brust M (2008) Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2:1639–1644. doi:10.1021/nn800330a10.1021/nn800330a ↗
66. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627. doi:10.1126/science.111439710.1126/science.1114397 ↗
67. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–347. doi:10.1016/j.jconrel.2006.06.01710.1016/j.jconrel.2006.06.017 ↗
68. Nikoobakht B, El-Sayed MA (2001) Evidence for bilayer assembly of cationic surfactants on the surface of gold nanorods. Langmuir 17:6368–6374. doi:10.1021/la010530o10.1021/la010530o ↗
69. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL (2008) Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett 8:302–306. doi:10.1021/nl072705610.1021/nl0727056 ↗
70. Oberdorster G, Sharp Z, Atudorei V et al (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445. doi:10.1080/0895837049043959710.1080/08958370490439597 ↗
71. Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH (2009) Nanotoxicology: characterizing the scientific literature, 2000–2007. J Nanopart Res 11:251–257. doi:10.1007/s11051-008-9579-510.1007/s11051-008-9579-5 ↗
72. Pan Y, Neuss S, Leifert A et al (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941–1949. doi:10.1002/smll.200700378ER10.1002/smll.200700378 ↗
73. Pan Y, Leifert A, Ruau D et al (2009) Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5(18):2067–2076. doi:10.1002/smll.20090046610.1002/smll.200900466 ↗
74. Parng C (2005) In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Dev 8:100–106
75. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta AK (2007) Cell selective response to gold nanoparticles. Nanomedicine 3:111–119. doi:10.1016/j.nano.2007.03.00510.1016/j.nano.2007.03.005 ↗
76. Pernodet N, Fang XH, Sun Y et al (2006) Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2:766–773. doi:10.1002/smll.200500492ER10.1002/smll.200500492 ↗
77. Qian XM, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie SM (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26:83–90. doi:10.1038/nbt137710.1038/nbt1377 ↗
78. Rosi NL, Mirkin CA (2005) Nanostructures in biodiagnostics. Chem Rev 105:1547–1562. doi:10.1021/cr030067f10.1021/cr030067f ↗
79. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312:1027–1030. doi:10.1126/science.112555910.1126/science.1125559 ↗
80. Ryan JA, Overton KW, Speight ME et al (2007) Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates. Anal Chem 79:9150–9159. doi:10.1021/ac071552410.1021/ac0715524 ↗
81. Sarin H, Kanevsky AS, Wu HT et al (2008) Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med 6:1–15. doi:10.1186/1479-5876-6-8010.1186/1479-5876-6-80 ↗
82. Sau TK, Murphy CJ (2004) Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir 20:6414–6420. doi:10.1021/la049463z10.1021/la049463z ↗
83. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21:10644–10654. doi:10.1021/la051371210.1021/la0513712 ↗
84. Skrabalak SE, Chen JY, Sun YG et al (2008) Gold nanocages: synthesis, properties, and applications. Acc Chem Res 41:1587–1595. doi:10.1021/ar800018v10.1021/ar800018v ↗
85. Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B 66:274–280. doi:10.1016/j.colsurfb.2008.07.00410.1016/j.colsurfb.2008.07.004 ↗
86. Stone JW, Sisco PN, Goldsmith EC, Baxter SC, Murphy CJ (2007) Using gold nanorods to probe cell-induced collagen deformation. Nano Lett 7:116–119. doi:10.1021/nl062248d10.1021/nl062248d ↗
87. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S (2006) Modification of gold nanorods using phospatidylcholine to reduce cytotoxicity. Langmuir 22:2–5. doi:10.1021/la052002910.1021/la0520029 ↗
88. Tervonen T, Linkov I, Figueira JR, Steevens J, Chappell M, Merad M (2009) Risk-based classification system of nanomaterials. J Nanopart Res 11:757–766. doi:10.1007/s11051-008-9546-110.1007/s11051-008-9546-1 ↗
89. Troutman TS, Barton JK, Romanowski M (2008) Biodegradable plasmon resonant nanoshells. Adv Mater 20:2604–2608. doi:10.1002/adma.20070302610.1002/adma.200703026 ↗
90. Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G (2005) Cellular uptake and toxicity of Au(55) clusters. Small 1:841–844. doi:10.1002/smll.20050010410.1002/smll.200500104 ↗
91. Turner M, Golovko VB, Vaughan OPH et al (2008) Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters. Nature 454:U31–981. doi:10.1038/nature0719410.1038/454031a ↗
92. Unfried K, Albrecht C, Klotz LO, Von Mikecz A, Grether-Beck S, Schins RPF (2007) Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1:52–71. doi:10.1080/0022293070131493210.1080/00222930701314932 ↗
93. Verma A, Uzun O, Hu YH et al (2008) Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 7:588–595. doi:10.1038/nmat220210.1038/nmat2202 ↗
94. Vesaratchanon S, Nikolov A, Wasan DT (2007) Sedimentation in nano-colloidal dispersions: effects of collective interactions and particle charge. Adv Colloid Interface Sci 134–35:268–278. doi:10.1016/j.cis.2007.04.02610.1016/j.cis.2007.04.026 ↗
95. Villiers CL, Freitas H, Couderc R, Villiers MB, Marche PN (2009) Analysis of the toxicity of gold nanoparticles on the immune system: effect on dendritic cell functions. J Nanopart Res 12:55–60. doi:10.1007/s11051-009-9692-010.1007/s11051-009-9692-0 ↗
96. Von Maltzahn G, Park JH, Agrawal A et al (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69:3892–3900. doi:10.1158/0008-5472.CAN-08-424210.1158/0008-5472.CAN-08-4242 ↗
97. Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19:316–317. doi:10.1038/8668410.1038/86684 ↗
98. Willets KA, Van Duyne RP (2007) Localized surface plasmon resonance spectroscopy and sensing. Annu Rev Phys Chem 58:267–297. doi:10.1146/annurev.physchem.58.032806.10460710.1146/annurev.physchem.58.032806.104607 ↗
99. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130:601–610. doi:10.1016/j.cell.2007.08.00610.1016/j.cell.2007.08.006 ↗
100. Zhang GD, Yang Z, Lu W, Zhang R, Huang Q, Tian M, Li L, Liang D, Li C (2009) Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumorxenografted mice. Biomaterials 30:1928–1936. doi:10.1016/j.biomaterials.2008.12.03810.1016/j.biomaterials.2008.12.038 ↗